FI813319L - 4,5-omaettade derivater av prostanoin syra - Google Patents

4,5-omaettade derivater av prostanoin syra

Info

Publication number
FI813319L
FI813319L FI813319A FI813319A FI813319L FI 813319 L FI813319 L FI 813319L FI 813319 A FI813319 A FI 813319A FI 813319 A FI813319 A FI 813319A FI 813319 L FI813319 L FI 813319L
Authority
FI
Finland
Prior art keywords
prostanoin
omaettade
derivater
syra
unsaturated
Prior art date
Application number
FI813319A
Other languages
English (en)
Finnish (fi)
Inventor
Paul Waddell Collins
Raphael Pappo
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of FI813319L publication Critical patent/FI813319L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/80—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
    • C07C59/82—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI813319A 1980-10-24 1981-10-23 4,5-omaettade derivater av prostanoin syra FI813319L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/200,356 US4322543A (en) 1979-11-28 1980-10-24 4,5-Unsaturated prostanoic acid derivatives

Publications (1)

Publication Number Publication Date
FI813319L true FI813319L (fi) 1982-04-25

Family

ID=22741378

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813319A FI813319L (fi) 1980-10-24 1981-10-23 4,5-omaettade derivater av prostanoin syra

Country Status (14)

Country Link
US (1) US4322543A (fr)
EP (1) EP0050849B1 (fr)
JP (1) JPS57102861A (fr)
AT (1) ATE5816T1 (fr)
AU (1) AU546626B2 (fr)
CA (1) CA1208633A (fr)
DE (1) DE3161898D1 (fr)
DK (1) DK469981A (fr)
ES (1) ES506507A0 (fr)
FI (1) FI813319L (fr)
IL (1) IL64126A0 (fr)
NO (1) NO813579L (fr)
PT (1) PT73874B (fr)
ZA (1) ZA817252B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011958A (en) * 1987-06-08 1991-04-30 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4785124A (en) * 1987-06-08 1988-11-15 G. D. Searle & Co. Process for preparing higher order cuprate complexes
US4777275A (en) * 1987-06-09 1988-10-11 G. D. Searle & Co. Process of preparing higher order cuprate complexes
US5191109A (en) * 1990-02-02 1993-03-02 Sumitomo Chemical Company, Limited Process for preparing optically active cyclopentenones
US5218139A (en) * 1990-12-27 1993-06-08 G. D. Searle & Co. Method for inhibiting IgE production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965143A (en) * 1974-03-26 1976-06-22 G. D. Searle & Co. 16-Oxygenated prostanoic acid derivatives
US4028419A (en) * 1976-01-08 1977-06-07 The Upjoin Company 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds
US4254285A (en) * 1977-12-08 1981-03-03 American Cyanamid Company 1-Hydroxymethyl-1-1-oxo prostane derivatives of the E and F series
US4311707A (en) * 1979-02-12 1982-01-19 American Cyanamid Company Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions

Also Published As

Publication number Publication date
ATE5816T1 (de) 1984-01-15
CA1208633A (fr) 1986-07-29
US4322543A (en) 1982-03-30
PT73874A (en) 1981-11-01
IL64126A0 (en) 1982-01-31
ES8301870A1 (es) 1983-01-01
JPS57102861A (en) 1982-06-26
AU7676881A (en) 1982-04-29
NO813579L (no) 1982-04-26
JPH039093B2 (fr) 1991-02-07
EP0050849B1 (fr) 1984-01-11
EP0050849A1 (fr) 1982-05-05
ES506507A0 (es) 1983-01-01
DK469981A (da) 1982-04-25
AU546626B2 (en) 1985-09-12
PT73874B (en) 1985-11-12
ZA817252B (en) 1983-01-26
DE3161898D1 (de) 1984-02-16

Similar Documents

Publication Publication Date Title
SE8008300L (sv) 4,5-omettade prostansyraderivat
FI813319L (fi) 4,5-omaettade derivater av prostanoin syra
DE3162089D1 (de) Antiinflammatory 4,5-diaryl-alpha-(polyfluoroalkyl)-1h-pyrrole-2-methanamines
DK267781A (da) 2,3-bis-hydroxybenzylderivater
ATE22293T1 (de) Substituierte tetrahydropyridazino(1,6a)benzimidazole.
IE820686L (en) Prostanoic acid derivatives.
SE7902404L (sv) 2,3-dihydro-4h-1-bensopyran-4-on-o-karbamoyloximer
ES507706A0 (es) Procedimiento para la fabricacion de derivados de 5,6,7,7atetrahidro-4h-tieno(3,2-c)-piridin-2-ona .
AU2133777A (en) 13, 14-didehydro prostaglandin
AU526670B2 (en) Production of 5.6 dihydro-2-methyl-n-phenyl-1,4-oxathiin-3- carboxamide
DK167182A (da) 5,6-o-isoalkylidenascorbinsyrederivater
FI813729L (fi) Nytt foerfarande foer framstaellning av 5,6,7,7a-tetrahydro-4h-tieno(3,2-c)-pyridin-2-onderivat
IE781069L (en) 3-(4-chromanylamino)-2-oxazolidinones
FI895129A0 (fi) Anordning foer att aostadkomma suspension och loesning av kalkstensmjoel, speciellt braend kalk, i vatten.
AU496087B2 (en) Prostaglandin-type, 1, 15 lactones
AU496088B2 (en) Prostaglandin-type 1, 9-lactones
SU606226A1 (ru) Автоматический номеронабиратель
AU496552B2 (en) Prostaglandin-type 1, 11-lactones
AU1428976A (en) Prostaglandin-type 1, 9-lactones
SU553245A1 (ru) Способ получени 8,8"-диокси-5,5"дихинолилдисульфида
AU496086B2 (en) Prostaglandin type 1, 15-lactones
FI893757A0 (fi) Foerfarande foer framstaellning av pentaerytril-tetrakis-/3-(3,5-ditert.butyl-4-hydroxifenyl) propionat.
NO861695L (no) Nye 10-(1,2-propadienyl)steroider.
NL189460C (nl) 2,6-methano-3-benzazocinederivaat.
IE812501L (en) 4,5-unsaturated-16-hydroxy prostanoic acid derivatives.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: G.D. SEARLE & CO